Bone marrow aplasia after pipobroman: an immune-mediated mechanism?
Triffet
A
A
Straetmans
N
N
Ferrant
A
A
D000368:Aged; D000369:Aged, 80 and over; D000741:Anemia, Aplastic / Q000139:chemically induced* / Q000188:drug therapy; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects* / Q000627:therapeutic use; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008875:Middle Aged; D010885:Pipobroman / Q000009:adverse effects* / Q000627:therapeutic use; D013920:Thrombocythemia, Essential / Q000188:drug therapy / Q000276:immunology
D018906:Antineoplastic Agents, Alkylating; D007166:Immunosuppressive Agents; D010885:Pipobroman; D016572:Cyclosporine